Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Starton Therapeutics Names Saleem Elmasri As Chief Financial Officer

PRIVATESep 08, 2026•about 3 hours ago

Position

Chief Financial Officer

Company

Starton Therapeutics

Saleem Elmasri
ParamusBiotechnologyHealthcare

Description

Starton Therapeutics has appointed Saleem Elmasri as Chief Financial Officer, succeeding Scott Kahn. Elmasri brings 20 years of experience in finance and will lead the corporate finance strategy as the company prepares for its upcoming IPO.

Company Information

Company

Starton Therapeutics

Location

215 COLLEGE ROAD, SUITE #300

Paramus, New Jersey, United States

About

Starton Therapeutics is a clinical-stage biotechnology company that is transforming standard-of-care therapies with proprietary dermal technology, so people with cancer can receive continuous treatment to live better, longer.

Don't miss Starton Therapeutics's next move

Get an email the moment Starton Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Pedro
Senior decision-maker at this company
••••••••@••••••••

See Pedro's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Starton Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Starton Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.